<DOC>
	<DOCNO>NCT00737971</DOCNO>
	<brief_summary>Triamcinolone Bevacizumab Intravitreal Treatment Diabetic Macular Edema</brief_summary>
	<brief_title>Efficacy Study Triamcinolone Bevacizumab Intravitreal Treatment Diabetic Macular Edema</brief_title>
	<detailed_description>Efficacy Study Triamcinolone Bevacizumab Intravitreal Treatment Diabetic Macular Edema</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>18 year age least Diagnosis diabetes mellitus ( type 1 type 2. one following consider sufficient evidence diabetes present : current regular use insulin treatment diabetes current regular use oral hypoglycemic agent treatment diabetes diabetes define american Diabetes Association ( ADA ) symptom diabetes ( polyuria , polydipsia , unexplained weight loss ) eighthhour fast plasma glucose &gt; 126 mg/dl Diabetic macular edema clinically observable associate diabetic retinopathy : without prior foveal treatment laser therapy photocoagulation peripherical macular laser , least 3 month absence macular ischemia fluorescein angiography baseline visit BCVA score 20 letter ( 20/400 ETDRS ) e 70 letter ( 20/40 ETDRS ) study eye measure ETDRS method qualification/baseline visit Retinal thickness &gt; 275um OCT One eye per patient chosen study . In case eye eligible , choose eye treat study medication another eye treat laser Taught hyaloid syndrome Uncontrolled systemic disease Initiation medical therapy diabetes change oral hypoglycemic agent insulin therapy within 4 month prior qualification visit Renal failure require hemodialysis peritoneal dialysis within 6 month prior qualification visit Any ocular condition study eye opinion investigator would prevent 2 line improvement visual acuity ( e.g . severe macular ischemia ) Presence branch retinal vein occlusion , central retinal vein occlusion , uveitis , pseudophakic cystoid edema condition study eye could contribute macular edema Presence epiretinal membrane study eye History IOP elevation response steroid treatment either eye History glaucoma optic nerve head change consistent glaucoma damage Ocular hypertension require 1 antiglaucoma medication maintain IOP &lt; 11mmhg qualification visit Presence anterior chamber intraocular lens study eye Active optic disc retinal neovascularization study eye qualification visit Active history choroidal neovascularization study eye</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>avastin</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>triamcinolone</keyword>
	<keyword>diabetic macular edema</keyword>
	<keyword>macular edema</keyword>
	<keyword>intravitreal injection</keyword>
</DOC>